one Phase II skin trial Evidence gap / no head-to-head or combination RCT exists as of 2025 Typical sermorelin dose / 200-500 mcg subcutaneous injection at bedtime Typical GHK-Cu dose / 1-2 mg subcutaneous or topical, 5 days per week Regulatory status / sermorelin: FDA-approved (NDA 19-559, withdrawn 2008 for commercial reasons)
Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice (in Eng)
Frequency of Metformin-Associated B12 Deficiency An association between metformin therapy and B12 deficiency was first reported in 1969
While DSIP occurs naturally in breast milk, supplemental doses have not been studied in pregnancy or lactation
10.1210/me.2012-1307 114
Stable gastric pentadecapeptide BPC 157 as therapy after surgical detachment of the quadriceps muscle for muscle-to-bone reattachment in rats2025Musculoskeletal BPC 157 promoted quadriceps muscle-to-bone reattachment after surgical detachment in rats, with consistent healing confirmed via ultrasonic, MRI, biomechanical, and functional assessments